A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
Oncoinvent Solutions AS
Oncoinvent Solutions AS
Lumicell, Inc.
Seagen Inc.
Merck Sharp & Dohme LLC
Corcept Therapeutics
GE Healthcare
Oncoinvent Solutions AS
Arsenal Biosciences, Inc.
CanariaBio Inc.
Hoffmann-La Roche
Genelux Corporation
Corcept Therapeutics